BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
NTB
The Bank of N.T. Butterfield & Son Limited
There isn't enough reported data to score NTB yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
NTB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
NTB's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like NTB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over NTB in the historical PE scenario, which offers more potential upside but is not a forecast.
NTB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $36.77 | -35% |
| Forward | 8.6x | $56.25 | — |
| Fair | 8.9x | $48.90 | -13% |
| Current | 10x | $56.25 | — |
| Expensive | 11x | $61.43 | +9.2% |
Historical ranges are pointers, not guarantees.
NTB's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over NTB on the outlook, with more favorable profitability expectations.
NTB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NTB, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
NTB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.55 | +20% |
| Q4 2025 | $5.47 | +16% |
| Q4 2024 | $4.71 | +2.8% |
| Q4 2023 | $4.58 | +6.8% |
| Q4 2022 | $4.29 | +32% |
| Q4 2021 | $3.26 | +12% |
| Q4 2020 | $2.90 | -12% |
| Q4 2019 | $3.30 | -5.7% |
| Q4 2018 | $3.50 | +27% |
NTB has the edge over BAC in the latest year-over-year earnings comparison.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
NTB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $606.8M | +4.6% |
| Q4 2024 | $579.9M | +0.2% |
| Q4 2023 | $578.6M | +5.3% |
| Q4 2022 | $549.3M | +9.9% |
| Q4 2021 | $499.7M | +1.1% |
| Q4 2020 | $494.2M | -7.2% |
| Q4 2019 | $532.6M | +2.9% |
| Q4 2018 | $517.8M | +14% |
NTB has the edge over BAC in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 39% | +6 points |
| Q4 2024 | 38% | +7.8 points |
| Q4 2023 | 39% | +6.1 points |
| Q4 2022 | 40% | +1.7 points |
| Q4 2021 | 33% | -0.8 points |
| Q4 2020 | 30% | +1.3 points |
| Q4 2019 | 33% | N/A |
| Q4 2018 | 38% | N/A |
NTB's operating margin was 39% last quarter, up 6 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
NTB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2018 | $277.8M | +25% |
| Q4 2017 | $222.5M | +32% |
NTB and BAC do not have enough comparable growth data to identify a winner.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
NTB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -8.2% | -3.6M shares |
| 1 year | -20% | -10M shares |
NTB has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $146.7M |
| Q4 2024 | $155.3M |
| Q4 2023 | $88.6M |
| Q4 2022 | $3.9M |
| Q4 2021 | $19.8M |
| Q4 2020 | $86.6M |
| Q4 2019 | $81.5M |
| Q4 2018 | $48.4M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
NTB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -6.2x | Net Cash |
| Q4 2024 | -7.2x | Net Cash |
| Q4 2023 | -5.9x | Net Cash |
| Q4 2022 | -7.5x | Net Cash |
| Q4 2021 | -8.5x | Net Cash |
| Q4 2020 | -14.7x | Net Cash |
| Q4 2019 | -10.7x | Net Cash |
| Q4 2018 | -7.9x | Net Cash |
NTB has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like NTB.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
NTB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.9 | Neutral |
| Stochastic | 8.3 | Oversold |
NTB's weekly RSI is 46 (neutral) and its Stochastic is 8 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
NTB PE vs Financial Services Sector
| Metric | NTB | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 21% below |
| PE % | 68 | 63 | 5 pts above |
NTB has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
NTB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $57.6 | 2.4% below |
| 20 week MA | $59.5 | 5.5% below |
| 50 week MA | $55.9 | 0.7% above |
| 100 week MA | $48.7 | 15% above |
| 200 week MA | $40.2 | 40% above |
NTB has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
NTB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.9 | $31.2 | -16% |
| 2021 | $31.2 | $38.0 | +22% |
| 2022 | $38.0 | $30.0 | -21% |
| 2023 | $30.0 | $32.0 | +6.8% |
| 2024 | $32.0 | $36.8 | +15% |
| 2025 | $36.8 | $50.5 | +37% |
| 2026 YTD | $50.5 | $56.3 | +11% |
NTB has the edge over BAC on returns for 2026, with the stronger performance.